MedElevator Войти в исследования
← Поиск публикаций

DOI 10.15585/mmwr.mm7406a4

Медицинская библиотека · MMWR. Morbidity and mortality weekly report · 2025

Trends in Cervical Precancers Identified Through Population-Based Surveillance - Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United States, 2008-2022.

Gargano Julia W, Stefanos Ruth, Dahl Rebecca M, Castilho Jessica L, Bostick Erica A, Niccolai Linda M, Park Ina U, Blankenship Sheelah, Brackney Monica M, Chan Kameny, Delikat Emily L, Ehlers Sara, Barrera Kimberly Gonzalez, Kurtz RaeAnne, Meek James I, Whitney Erin, Vigar Marissa, Unger Elizabeth R, Markowitz Lauri E, HPV-IMPACT Working Group

СтатьяПеревод в очереди

Аннотация

In 2006, human papillomavirus (HPV) vaccine was first recommended in the United States to prevent cancers and other diseases caused by HPV; vaccination coverage increased steadily through 2021, and increasing numbers of young women had received HPV vaccine as children or adolescents. Since 2008, CDC has monitored incidence of precancerous lesions (cervical intraepithelial neoplasia [CIN] grades 2-3 and adenocarcinoma in situ [AIS], collectively CIN2+), which are detected through cervical cancer screening and can be used as an intermediate outcome for monitoring vaccination impact, via the five-site Human Papillomavirus Vaccine Impact Monitoring Project. This analysis describes trends in incidence of CIN2+ and CIN3+ (i.e., CIN grade 3 and AIS) lesions during 2008-2022. Among women aged 20-24 years who were screened for cervical cancer, rates during 2008-2022 decreased for CIN2+ by 79%, and for CIN3+ by 80%. In the same period, CIN3+ rates among screened women aged 25-29 years decreased by 37%. These data are consistent with considerable impact of HPV vaccination for preventing cervical precancers among women in the age groups most likely to have been vaccinated, and support existing recommendations to vaccinate children at the routinely recommended ages as a cancer prevention measure.

Для цитирования: Gargano Julia W, Stefanos Ruth, Dahl Rebecca M, Castilho Jessica L, Bostick Erica A, Niccolai Linda M, Park Ina U, Blankenship Sheelah, Brackney Monica M, Chan Kameny, Delikat Emily L, Ehlers Sara, Barrera Kimberly Gonzalez, Kurtz RaeAnne, Meek James I, Whitney Erin, Vigar Marissa, Unger Elizabeth R, Markowitz Lauri E, HPV-IMPACT Working Group. Trends in Cervical Precancers Identified Through Population-Based Surveillance - Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United States, 2008-2022.. MMWR. Morbidity and mortality weekly report. 2025. DOI: 10.15585/mmwr.mm7406a4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.